Cargando…

Correction to: PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling

Detalles Bibliográficos
Autores principales:	Yao, Bing, Gui, Tao, Zeng, Xiangwei, Deng, Yexuan, Wang, Zhi, Wang, Ying, Yang, Dongjun, Li, Qixiang, Xu, Peipei, Hu, Ruifeng, Li, Xinyu, Chen, Bing, Wang, Jin, Zen, Ke, Li, Haitao, Davis, Melissa J., Herold, Marco J., Pan, Hua-Feng, Jiang, Zhi-Wei, Huang, David C. S., Liu, Ming, Ju, Junyi, Zhao, Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491380/ https://www.ncbi.nlm.nih.gov/pubmed/34607606 http://dx.doi.org/10.1186/s13073-021-00966-z

Ejemplares similares

PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling
por: Yao, Bing, et al.
Publicado: (2021)

The SMARCA4(R1157W) mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer
por: Zeng, Xiangwei, et al.
Publicado: (2023)

PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression
por: Liu, Ming, et al.
Publicado: (2020)

AURKB promotes gastric cancer progression via activation of CCND1 expression
por: Nie, Min, et al.
Publicado: (2020)

TCF3 is epigenetically silenced by EZH2 and DNMT3B and functions as a tumor suppressor in endometrial cancer
por: Gui, Tao, et al.
Publicado: (2021)

Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023)

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
por: Cantley, Jennifer, et al.
Publicado: (2022)

Label-free quantitative proteomics identifies Smarca4 is involved in vascular calcification
por: Wang, Chan, et al.
Publicado: (2019)

High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer
por: Guerrero-Martínez, Jose A., et al.
Publicado: (2018)

Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review
por: Duan, Huanli, et al.
Publicado: (2021)

SMARCA4‑deficient non‑small cell lung cancer with an EGFR mutation: A case report
por: Sun, Lijun, et al.
Publicado: (2023)

A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers
por: Peng, Ling, et al.
Publicado: (2021)

Thoracic SMARCA4-deficient undifferentiated tumor
por: Jiang, Jiapeng, et al.
Publicado: (2023)

Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type
por: Jelinic, Petar, et al.
Publicado: (2016)

PRMT5 promotes colorectal cancer growth by interaction with MCM7
por: Li, Xiangwei, et al.
Publicado: (2021)

Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion
por: Liu, Yi, et al.
Publicado: (2023)

The genetic polymorphisms of ZC3HC1 and SMARCA4 are associated with hypertension risk
por: Ma, Huijun, et al.
Publicado: (2019)

SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines
por: Ehrenhöfer-Wölfer, Katharina, et al.
Publicado: (2019)

The Methyltransferases PRMT4/CARM1 and PRMT5 Control Differentially Myogenesis in Zebrafish
por: Batut, Julie, et al.
Publicado: (2011)

PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades
por: Yan, Yongrong, et al.
Publicado: (2021)

Is the case really a SMARCA4‐deficient thoracic sarcoma?
por: Kunimasa, Kei
Publicado: (2020)

Case Series of SMARCA4-Deficient Undifferentiated Esophageal Carcinoma
por: Ahmed, Omar T, et al.
Publicado: (2022)

PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma
por: Xia, Tian, et al.
Publicado: (2021)

Clinical characteristics and prognostic analysis of SMARCA4‐deficient non‐small cell lung cancer
por: Liang, Xiyue, et al.
Publicado: (2023)

Tissue-specific SMARCA4 binding at active and repressed regulatory elements during embryogenesis
por: Attanasio, Catia, et al.
Publicado: (2014)

Protein arginine methyltransferases PRMT1, PRMT4/CARM1 and PRMT5 have distinct functions in control of osteoblast differentiation
por: Dashti, Parisa, et al.
Publicado: (2023)

Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss
por: Zhu, Xianbing, et al.
Publicado: (2023)

Suv4-20h1 promotes G1 to S phase transition by downregulating p21(WAF1/CIP1) expression in chronic myeloid leukemia K562 cells
por: Wu, Yupeng, et al.
Publicado: (2018)

Protein arginine N-methyltransferase 4 (PRMT4) contributes to lymphopenia in experimental sepsis
por: Lai, Yandong, et al.
Publicado: (2023)

Correction: PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma
por: Xia, Tian, et al.
Publicado: (2021)

Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer
por: Herold, Natalie, et al.
Publicado: (2023)

Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor
por: Lin, Ying, et al.
Publicado: (2023)

Variants in the SMARCA4 gene was associated with coronary heart disease susceptibility in Chinese han population
por: Guo, Xuan, et al.
Publicado: (2016)

SMARCA4‐deficient lung tumour that presented with haemoptysis and progressed rapidly
por: Inoue, Mari, et al.
Publicado: (2020)

Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours
por: Genestie, Catherine, et al.
Publicado: (2019)

Response to ‘Is the case really a SMARCA4‐deficient thoracic sarcoma?’
por: Takada, Kohichi, et al.
Publicado: (2020)

SMARCA4-deficient undifferentiated thoracic tumor: A case report
por: Kwon, Hee Jung, et al.
Publicado: (2023)

Sex-specific association of SH2B3 and SMARCA4 polymorphisms with coronary artery disease susceptibility
por: Ji, Yuqiang, et al.
Publicado: (2017)

Complex Alternative Splicing of the Smarca2 Gene Suggests the Importance of Smarca2-B Variants
por: Yang, Min, et al.
Publicado: (2011)

Regulation of 4-HNE via SMARCA4 Is Associated with Worse Clinical Outcomes in Hepatocellular Carcinoma
por: Watabe, Shiori, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tldddo5q2mo9gaap583hsutg4u